Join the Otezla group to help and get support from people like you.
Otezla News
FDA Approves Otezla (Apremilast) for the Treatment of Pediatric Patients 6 years of Age and Older With Moderate to Severe Plaque Psoriasis
Optum RX: April 25, 2024. Today, the FDA approved Amgen’s Otezla (apremilast), for the treatment of pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe p...
FDA Approves Otezla (apremilast) for the Treatment of Adult Patients with Plaque Psoriasis, Regardless of Severity Level
THOUSAND OAKS, Calif., Dec. 20, 2021 /PRNewswire/ – Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla® (apremilast) for the treatment of adult ...
FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
SUMMIT, N.J.--(BUSINESS WIRE) July 19, 2019 – Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast) 30 mg twice daily (BID) for the...
FDA Approves Otezla (apremilast) for Moderate to Severe Plaque Psoriasis
SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast), the Company's oral, selective inhibitor of...
Further information
Related condition support groups
Psoriatic Arthritis, Behcet's Disease, Plaque Psoriasis